{{Rsnum
|rsid=284924
|Chromosome=16
|position=77009729
|Orientation=plus
|GMAF=0.1873
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 59.6 | 35.1 | 5.3
| HCB | 71.1 | 28.9 | 0.0
| JPT | 93.2 | 4.5 | 2.3
| YRI | 90.2 | 9.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 71.1 | 28.9 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23920401
|Title=Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients
}}

{{on chip | FTDNA}}